Avenge Bio, Inc., a biotechnology company developing the LOCOcyte immunotherapy platform for the precision administration of potent immune effector molecules to treat solid tumors, ...
Avenge Bio, Inc., ("Avenge" or the "Company") a biotechnology company developing the LOCOcyte™ immunotherapy platform for the precision administration of potent immune effector molecules...